The Immunoregulatory Role of Myeloid-Derived Suppressor Cells in the Pathogenesis of Rheumatoid Arthritis

被引:23
|
作者
Yan, Lan [1 ]
Liang, Mingge [1 ]
Yang, Tong [1 ]
Ji, Jinyu [1 ]
Jose Kumar Sreena, Goutham Sanker [1 ]
Hou, Xiaoqiang [2 ]
Cao, Meiqun [3 ]
Feng, Zhitao [1 ,2 ]
机构
[1] China Three Gorges Univ, Med Coll, Yichang, Peoples R China
[2] China Three Gorges Univ, Coll Clin Med Sci 1, Inst Rheumatol, Yichang, Peoples R China
[3] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Inst Geriatr, Shenzhen, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
myeloid-derived suppressor cell; rheumatoid arthritis; immune cell; immune regulation; cell therapy; COLLAGEN-INDUCED ARTHRITIS; TH17; CELLS; BONE LOSS; T-CELL; DIFFERENTIATION; SUBPOPULATIONS; DISEASE;
D O I
10.3389/fimmu.2020.568362
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) are a group of cells that regulate the immune response and exert immunosuppressive effects on various immune cells. Current studies indicate that MDSCs have both anti-inflammatory effects and proinflammatory effects on rheumatoid arthritis (RA) and RA animal models. MDSCs inhibit CD4(+)T cells, which secrete proinflammatory factors such as IFN-gamma, IL-2, IL-6, IL-17, and TNF-alpha, by inhibiting iNOS, ROS, and IFN-gamma and promoting the production of the anti-inflammatory factor IL-10. MDSCs can suppress dendritic cells by reducing MHC-II and CD86 expression, expand Treg cellsin vitrothrough the action of IL-10, inhibit B cells through NO and PGE(2), and promote Th17 cell responses by secreting IL-1 beta. As a type of osteoclast precursor cell, MDSCs can differentiate into osteoclasts through activation of the NF-kappa B pathway via IL-1 alpha. Overall, our study reviews the research progress related to MDSCs in RA, focusing on the effects of MDSCs on various types of cells and aiming to provide ideas to help reveal the important role of MDSCs in RA.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Role of myeloid-derived suppressor cells in fungal infections
    Hartl, D.
    [J]. MYCOSES, 2015, 58 : 23 - 23
  • [32] Role of myeloid-derived suppressor cells in tumor recurrence
    Cole, Kathryn
    Al-Kadhimi, Zaid
    Talmadge, James E.
    [J]. CANCER AND METASTASIS REVIEWS, 2023, 42 (01) : 113 - 142
  • [33] The role of myeloid-derived suppressor cells in tumor development
    Ortiz, Myrna L.
    Cheng, Pingyan
    Luetteke, Noreen
    Youn, Je-In
    Gabriloyich, Dmitry I.
    [J]. CANCER RESEARCH, 2011, 71
  • [34] The role of myeloid-derived suppressor cells in hematologic malignancies
    Gunes, Emine Gulsen
    Rosen, Steven T.
    Querfeld, Christiane
    [J]. CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 518 - 526
  • [35] Myeloid-derived suppressor cells and their role in pancreatic cancer
    Pergamo, M.
    Miller, G.
    [J]. CANCER GENE THERAPY, 2017, 24 (03) : 100 - 105
  • [36] Role of myeloid-derived suppressor cells in tumor immunotherapy
    Martin, Francois
    Apetoh, Lionel
    Ghiringhelli, Francois
    [J]. IMMUNOTHERAPY, 2012, 4 (01) : 43 - 57
  • [37] The role of myeloid-derived suppressor cells in glioma microenvironment
    Gao, Ce
    Wang, Aidong
    [J]. Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2019, 36 (03): : 515 - 520
  • [38] The Role of Myeloid-Derived Suppressor Cells in Viral Infection
    O'Connor, Megan A.
    Rastad, Jessica L.
    Green, William R.
    [J]. VIRAL IMMUNOLOGY, 2017, 30 (02) : 82 - 97
  • [39] The role of myeloid-derived suppressor cells in gastrointestinal cancer
    Cui, Cheng
    Lan, Penglin
    Fu, Li
    [J]. CANCER COMMUNICATIONS, 2021, 41 (06) : 442 - 471
  • [40] Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS
    Velegraki, Maria
    Stiff, Andrew
    Papadaki, Helen A.
    Li, Zihai
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)